No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.

F. N. Lauw; J. T. van Der Meer; J. de Metz; S. A. Danner; T. van Der Poll

doi:10.1086/318705

No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.

F. N. Lauw^*, J. T. van Der Meer, J. de Metz, S. A. Danner, T. van Der Poll

^*Corresponding author for this work

Internal medicine

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-gamma (IFN-gamma) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-gamma therapy did not produce sustained benefit.

Original language	English
Pages (from-to)	e81-82
Journal	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume	32
Issue number	4
DOIs	https://doi.org/10.1086/318705
Publication status	Published - 15 Feb 2001

Access to Document

10.1086/318705

Cite this

Lauw, F. N., van Der Meer, J. T., de Metz, J., Danner, S. A., & van Der Poll, T. (2001). No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 32(4), e81-82. https://doi.org/10.1086/318705

@article{612a5e99b1094586a33d21188b1f295a,

title = "No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.",

abstract = "Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-gamma (IFN-gamma) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-gamma therapy did not produce sustained benefit.",

author = "Lauw, {F. N.} and {van Der Meer}, {J. T.} and {de Metz}, J. and Danner, {S. A.} and {van Der Poll}, T.",

year = "2001",

month = feb,

day = "15",

doi = "10.1086/318705",

language = "English",

volume = "32",

pages = "e81--82",

journal = "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",

issn = "1058-4838",

number = "4",

}

Lauw, FN, van Der Meer, JT, de Metz, J, Danner, SA & van Der Poll, T 2001, 'No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 32, no. 4, pp. e81-82. https://doi.org/10.1086/318705

No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection. / Lauw, F. N.; van Der Meer, J. T.; de Metz, J. et al.

In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 32, No. 4, 15.02.2001, p. e81-82.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.

AU - Lauw, F. N.

AU - van Der Meer, J. T.

AU - de Metz, J.

AU - Danner, S. A.

AU - van Der Poll, T.

PY - 2001/2/15

Y1 - 2001/2/15

N2 - Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-gamma (IFN-gamma) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-gamma therapy did not produce sustained benefit.

AB - Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-gamma (IFN-gamma) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-gamma therapy did not produce sustained benefit.

UR - http://www.scopus.com/inward/record.url?scp=18044404841&partnerID=8YFLogxK

U2 - 10.1086/318705

DO - 10.1086/318705

M3 - Article

C2 - 11181141

AN - SCOPUS:18044404841

VL - 32

SP - e81-82

JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

SN - 1058-4838

IS - 4

ER -

No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.

Abstract

Access to Document

Other files and links

Cite this